Massachusetts Injects $8M into Joint UMass Boston, Dana-Farber/Harvard Cancer Center | GenomeWeb

NEW YORK (GenomeWeb News) – The Massachusetts Life Sciences Center has provided $8 million in funding to support continued development of the Center for Personalized Cancer Therapy, a joint initiative between the University of Massachusetts Boston and the Dana-Farber/Harvard Cancer Center (DF/HCC), MSLC said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.